Is there human evidence for IGF-1 LR3?

1 of the 1 studies indexed for IGF-1 LR3 observed people. The rest are preclinical. This index does not evaluate whether IGF-1 LR3 is safe or effective for any use.

What is not established about IGF-1 LR3?

This index does not evaluate whether IGF-1 LR3 is safe or effective for any use. Material sold by the vendors indexed here is labeled for laboratory research use only and is not a regulator-approved medicine in that form. No dosing, protocol or human-use guidance is provided or implied anywhere in this index.

Evidence digest

What the research on IGF-1 LR3 actually shows

The indexed literature on IGF-1 LR3 includes human clinical or observational records (1 human-clinical or observational record). This digest describes the shape of that evidence and links the records behind it. It does not judge whether IGF-1 LR3 is safe or effective for any purpose, and nothing here is medical advice — the material sold by the vendors in this index is labeled for laboratory research use only.

Updated 25 Aug 2026 · 1 studies indexed · 1 human · compound record

Studies indexed: 1
Human evidence: 1
Preclinical only: 0

What is and is not established

What the literature supports

Human clinical or observational records are indexed for IGF-1 LR3 (1).
Published research is indexed back to 1993, with roughly 49 PubMed records located.
It is listed by one or more vendors tracked in this index.

What is NOT established

This index does not evaluate whether IGF-1 LR3 is safe or effective for any use.
Material sold by the vendors indexed here is labeled for laboratory research use only and is not a regulator-approved medicine in that form.
No dosing, protocol or human-use guidance is provided or implied anywhere in this index.

Studies indexed

1 human — controlled trial

Each row links to that study's permalink, where every digest citing it is listed. Findings are reported as the paper reported them — an animal result is not restated as a human one.
Study	Evidence type	Model	n	What it reported	Source
Differential effects of insulin-like growth factor-I and gonadotropins on the proliferative activity of two subgroups of granulosa cells: cumulus oophorus and mural granulosa cellsFertility and sterility · 2001	Human — controlled trial	Not recorded	—	To evaluate the physiological role of insulin-like growth factor-I (IGFI) and its interaction with gonadotropins in cell replication of two types of granulosa cells (cumulus oophorus, CC) and mural granulosa cells (MGC). Controlled randomized study of the action and interaction of gonadotropins and IGFI on granulosa cell replication in the rat. A university reproductive biology laboratory. The study examined the in vivo treatment with gonadotropins or an analogue of IGFI, lon…	PMID 11334915

Vendors listing IGF-1 LR3

Ranked view →

The evidence above describes the published literature. What any individual vial contains is a separate question, answered by that vendor’s certificate records rather than by any study on this page.

Vendor	Score · Coverage	Certificates
PeptidePlugs	89.790%	1	profile →
American Peptides	83.6100%	1	profile →
Northline Labs	79.493%	1	profile →
NeuroLabs Research	79.386%	0	profile →
Licensed Peptides	7789%	1	profile →
Evo Labs Research	75.789%	0	profile →
Modern Aminos	74100%	1	profile →
GenX Peptides	70.868%	0	profile →
Vertex Labs	70.170%	1	profile →
Eternal Peptides	68.265%	0	profile →
Mile High Compounds	65.494%	0	profile →
Sports Technology Labs	56.174%	0	profile →

How to read this page

This digest describes what published research exists and what it does not establish. It is not a recommendation, contains no dosing information or protocols, and makes no claim that any compound is safe or effective for any purpose. Material listed by indexed vendors is labeled for laboratory research use only.